High prevalence of cardiac valve disease in acromegaly: An observational, analytical, case-control study

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 7, 2003, Pages 3196-3201

  Colao, Annamaria ^a   Spinelli, Letizia ^a   Marzullo, Paolo ^a   Pivonello, Rosario ^a   Petretta, Mario ^a   Di Somma, Carolina ^a   Vitale, Giovanni ^a   Bonaduce, Domenico ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADULT; AGE; AGED; ANALYTIC METHOD; AORTA VALVE DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GENDER; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; MITRAL VALVE DISEASE; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VALVULAR HEART DISEASE;

ACROMEGALY; ADULT; AGED; AORTIC VALVE STENOSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; PREVALENCE;

EID: 0037961032     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021099     Document Type: Article

References (44)

1. Wright AD, Hill DM, Lowy C, Fraser TR 1970 Mortality in acromegaly. Q J Med 39:1-16
2. Bates AS, Van't Hoff W, Jones JM, Clayton RN 1993 An audit of outcome of treatment in acromegaly. Q J Med 86:293-299
3. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK 1994 Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95-102
4. Orme SM, McNally RJ, Cartwright RA, Belchetz PE 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83:2730-2734
5. Colao A, Marzullo P, Di Somma C, Lombardi G 2001 Growth hormone and the heart. Clin Endocrinol (Oxf) 54:137-154
6. Huchard H 1895 Anatomie pathologique, lesions et trouble cardiovasculaires de l'acromegalie. J Practiciens 9:249-250
7. Courville C, Mason VR 1938 The heart in acromegaly. Arch Intern Med 61:704-713
8. Hejtmancik MR, Bradfield JY, Herrmann GR 1951 Acromegaly and the heart: a clinical and pathologic study. Ann Intern Med 34:1445-1456
9. Lie JT, Grossman SJ 1980 Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 100:41-52
10. Smallridge RC, Rajfer S, Davia J, Schaaf M 1979 Acromegaly and the heart. An echocardiographic study. Am J Med 66:22-27
11. McGuffin WLJr, Sherman BM, Roth J, Gorden P, Kahn CR, Roberts WC, Frommer PL 1974 Acromegaly and cardiovascular disorders: a prospective study. Ann Intern Med 81:11-18
12. Savage DD, Henry WL, Eastman RC, Borer JS, Gorden P 1979 Echocardiographic assessment of cardiac anatomy and function in patients. Am J Med 67:823-829
13. Hayward RP, Emanuel RW, Nabarro JDN 1987 Acromegalic heart disease: influence of treatment of the acromegaly on the heart. Q J Med 62:41-58
14. Morvan D, Komajda M, Grimaldi A, Turpin G, Grosgogeat Y 1991 Cardiac hypertrophy and function in asymptomatic acromegaly. Eur Heart J 12: 666-672
15. Fazio S, Cittadini A, Sabatini D, Merola B, Colao A, Biondi B, Lombardi G, Saccà L 1993 Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J 14:26-33
16. Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A 2000 Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 85:193-199
17. Marzullo P, Cuocolo A, Ferone D, Pivonello R, Salvatore M, Lombardi G, Colao A 2000 Cardiac effect of thyrotoxicosis in acromegaly. J Clin Endocrinol Metab 85:1426-1432
18. Rodrigues EA, Caruana MP, Lahiri A, Nabarro JD, Jacobs HS, Raftery EB 1989 Subclinical cardiac dysfunction in acromegaly evidence for a specific disease of heart muscle. Br Heart J 62:185-194
19. Sicolo N, Bui F, Sicolo M, Varotto L, Martini C, Macor C, Federspil G 1993 Acromegalic cardiopathy: a left ventricular scintigraphic study. J Endocrinol Invest 16:123-127
20. Baldelli R, Ferretti E, Jaffrain-Rea ML, Iacobellis G, Minniti G, Caracciolo B, Moroni C, Cassone R, Gulino A, Tamburrano G 1999 Cardiac effects of lanreotide, a slow release somatostatin analog, in acromegalic patients. J Clin Endocrinol Metab 84:575-532
21. Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte A, Salvatore M, Lombardi G 1999 Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study. J Clin Endocrinol Metab 84:1518-1523
22. Hradec J, Kral J, Janota T, Krsek M, Hana V, Marek J, Malik M 1999 Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog). Am J Cardiol 83:1506-1509
23. Ohtsuka G, Aomi S, Koyanagi H, Tsukui H, Tomizawa Y, Hashimoto A, Sakomura Y 1997 Heart valve operation in acromegaly. Ann Thor Surg 64: 390-393
24. Zlatareva N, Andreeva M, Angelova I 2000 Echocardiographic evaluation of left ventricular function in acromegaly patients [Abstract]. J Bulgarian Soc Endocrinol 000:000-000
25. Colao A, Lombardi G 1998 Growth hormone and prolactin excess. Lancet 352:1455-1461
26. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
27. 1996 Hypertension control. Report of a WHO expert committee. WHO Tech Rep Ser 862:1-83
28. DECODE Study Group on behalf of the European Diabetes Epidemiology Group 1999 Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621
29. Sahn DJ, De Maria A, Kissio J, Weyman A 1978 The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiography measurements. Circulation 58:1072-1083
30. Feigenbaum H 1994 Echocardiography, 5th Ed. Philadelphia: Lea and Febiger
31. Lindroos M, Kupari M, Heikkila J, Tilvis R 1994 Predictors of left ventricular mass in old age: an echocardiographic, clinical and biochemical investigation of a random population sample. Eur Heart J 15:769-780
32. Palmieri V, Wachtell K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, Nieminen MS, Dahlof B, de Simone G, Devereux RB 2001 Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. Hypertension 141:784-791
33. Matsumoto M, Sekimoto H, Gotiya Y, Matsumoto M, Takasaki M, Tsuchiya H, Nakatani A, Takizawa S 1990 Echocardiographic assessment of mitral annular calcification in hypertrophic cardiomyopathy with asymmetric septal hypertrophy and healthy elderly cases. Nippon Ronen Igakkai Zasshi 27: 728-735
34. Melmed S 2001 Acromegaly and cancer: not a problem. J Clin Endocrinol Metab 86:2929-2934
35. Swearingen B, Barker FGII, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT 1998 Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426
36. Lim MJ, Barkan AL, Buda AJ 1992 Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Ann Intern Med 117:719-726
37. Pereira J, Rodriguez-Puras MJ, Leal-Cerro A, Martinez A, Garcia-Luna PP, Gavilan I, Pumar A, Astorga R 1991 Acromegalic cardiopathy improves after treatment with increasing doses of octreotide. J Endocrinol Invest 14:17-23
38. Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Florimonte L, Salvatore M, Lombardi G 1999 Effects of one-year treatment with octreotide on cardiac performance in patients with acromegaly. J Clin Endocrinol Metab 84:17-23
39. Colao A, Marzullo P, Ferone D, Spinelli L, Cuocolo A, Bonaduce D, Salvatore M, Boerlin V, Lancranjan I, Lombardi G 2000 Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly. J Clin Endocrinol Metab 86:3132-3140
40. Colao A, Marzullo P, Cuocolo A, Spinelli L, Pivonello R, Bonaduce D, Salvatore M, Lombardi G 2003 Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin Endocrinol (Oxf) 85:169-176
41. Cable DG, Dearani JA, O'Brien T, Orszulak TA, Puga FJ, Schaff HV 2000 Surgical treatment of valvular heart disease in patients with acromegaly. J Heart Valve Dis 9:828-831
42. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, benjamin EJ 2001 Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83: 897-902
43. Minniti G, Moroni C, Jaffrain-Rea ML, Esposito V, Santoro A, Affricano C, Cantore G, Tamburrano G, Cassone R 2001 Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clin Endocrinol (Oxf) 55:307-313
44. Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte AM, Pivonello R, Salvatore M, Lombardi G 2001 Is the acromegalic cardiomyopathy reversible? Effect of 5 year normalization of growth hormone and insulin-like growth factor-I levels on cardiac performance. J Clin Endocrinol Metab 86:1551-1557